Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Certain mice without specific receptors or mast cells don't lose hair from stress.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

The study suggests that hypothyroidism may cause alopecia areata.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

A man's skin condition was misdiagnosed and later identified as a rare type of skin cancer, which did not improve with treatment.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Understanding the genetics of alopecia areata could lead to better treatments.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

New therapies are being developed that target integrin pathways to treat various diseases.

Immune changes and specific genes contribute to male hair loss.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.